Rohan Naahar is a News Writer for Collider. From Francois Ozon to David Fincher, he'll watch anything once. He has covered everything from Marvel to the Oscars, and Marvel at the Oscars. He also ...
Jeffrey is a freelance features writer at Collider. He is an MPA-accredited entertainment journalist and a Tomatometer-approved critic based in the LA area. He graduated from the University of Texas ...
A Kentucky jury ordered a ghost gun company to pay $104 million in damages to a Louisville family in a wrongful death lawsuit ...
But unlike either of those two summer destinations, Widow’s Bay is under a centuries-old curse, and things are getting dangerous, just in time for tourist season. In the opening episodes, we learn ...
Graphic novels have gone from niche to mainstream. As illustrator Karen Harte releases her publisher's first original YA graphic novel, she tells Colin Sheridan why the medium is perfectly suited to a ...
Josh Cotts is the Lead Features and Lists Editor at GameRant. He graduated Summa Cum Laude from Arizona State University in 2019 with a B.A. in Mass Communications & Media Studies and has been ...
The 23rd edition of the international soccer championship tournament starts Thursday (June 11) — watch matches online for free. By Rudie Obias All products and services featured are independently ...
In a new book, Caroline Tracey explores the mysteries and beauty of salt lakes. By Robert Sullivan Robert Sullivan, a contributing editor at A Public Space, is the author of seven books, including ...
The CEO of McDonald’s was ruthlessly mocked across social media after posting a viral video of himself struggling to chomp down on a new super-sized menu item — which he oddly called a “product” — at ...
If you purchase an independently reviewed product or service through a link on our website, Variety may receive an affiliate commission. In 2026, with the introduction of UFC events and a subscription ...
Novartis is looking to build up its cardiovascular drug pipeline and it’s now partnering with Unnatural Products to support the effort. The pharmaceutical company is committing up to $100 million to ...
Unnatural Products unveiled a deal with Novartis worth up to $1.8 billion to develop macrocyclic peptide therapeutics. The biotechnology company developing macrocyclic peptides to address previously ...